Sungwhan An is the Founder and Chief Executive Officer of Genomictree, Inc.; molecular diagnostic company based in South Korea since 2000. He is an Adjunctive Professor in Cancer Center of Yonsei University, College of Medicine, South Korea and also had been worked as aResearch Assistant Professor from 2003 to 2009. After that he earned PhD degree in the field of molecular virology at the University of Texas at Austin in U.S.A. He then went through a Postdoctoral training course involved in translational research work investigating transcriptomics in HCV infection using DNA microarray at Dr. Harry Greenberg’s lab in the Stanford University School of Medicine from early 1999 to late 2000. Currently his interest is to discover and develop new DNA methylation biomarkers for the detection of cancers in non-invasive way. In addition, he has been focusing to develop multiplex assay technique for the multiple markers including multiple cancer mutations and infectious agents. Sungwhan An is the Founder and Chief Executive Officer of Genomictree, Inc.; molecular diagnostic company based in South Korea since 2000. He is an Adjunctive Professor in Cancer Center of Yonsei University, College of Medicine, South Korea and also had been worked as aResearch Assistant Professor from 2003 to 2009. After that he earned PhD degree in the field of molecular virology at the University of Texas at Austin in U.S.A. He then went through a Postdoctoral training course involved in translational research work investigating transcriptomics in HCV infection using DNA microarray at Dr. Harry Greenberg’s lab in the Stanford University School of Medicine from early 1999 to late 2000. Currently his interest is to discover and develop new DNA methylation biomarkers for the detection of cancers in non-invasive way. In addition, he has been focusing to develop multiplex assay technique for the multiple markers including multiple cancer mutations and infectious agents.

Surgery and Medicine